- Home
- FNGR vs SCNX Comparison
FNGR vs SCNX Comparison
Compare FNGR & SCNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FNGR | SCNX |
|---|---|---|
| Founded | 2016 | 2010 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Other Pharmaceuticals |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.9M | 16.2M |
| IPO Year | 2014 | 2019 |
Fundamental Metrics
Financial Performance| Metric | FNGR | SCNX |
|---|---|---|
| Price | $0.15 | $2.85 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 8.5M | 42.0K |
| Earning Date | 10-15-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $24,132,261.00 | $3,831,778.00 |
| Revenue This Year | N/A | $1,009.57 |
| Revenue Next Year | N/A | $259.51 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 30.72 |
| 52 Week Low | $0.13 | $2.70 |
| 52 Week High | $1.70 | $106.25 |
Technical Indicators
Market Signals| Indicator | FNGR | SCNX |
|---|---|---|
| Relative Strength Index (RSI) | 44.30 | 46.73 |
| Support Level | $0.14 | N/A |
| Resistance Level | $0.37 | $11.68 |
| Average True Range (ATR) | 0.02 | 7.18 |
| MACD | -0.00 | -0.69 |
| Stochastic Oscillator | 10.12 | 0.26 |
Price Performance
Historical ComparisonAbout FNGR FingerMotion Inc.
FingerMotion Inc is engaged in the provision of mobile payment and recharge services in the Chinese market. The Company organizes its operations across four primary areas: telecommunications products and services, marketplace platform and digital commerce infrastructure solutions, data and analytics platform solutions, and Advanced Technology And Platform Solutions. The company generates majority of revenue from telecommunications products and services segment. This segment includes mobile payment and recharge services, as well as enterprise messaging services such as short message services (SMS) and multimedia messaging services (MMS).
About SCNX Scienture Holdings Inc.
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on the commercialization and development of products for the treatment of cardiovascular (CVS) and Central Nervous System (CNS) diseases. Scienture LLC launched its first commercial product for hypertension and is in the process of commercializing its second product for the treatment of opioid overdose. Its development pipeline consists of a broad range of novel product candidates including new potential treatments for migraine, thrombosis, pain and other related disorders.